Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|September 21, 2012
JAK2 inhibitors in the treatment of myeloproliferative neoplasmsRaoul Tibes, James M Bogenberger, Holly L Geyer, et al.Mediators of Inflammation|November 6, 2015
Impact of Inflammation on Myeloproliferative Neoplasm Symptom DevelopmentHolly L Geyer, Amylou C Dueck, Robyn M Scherber, et al.Hospital Practice (1995)|June 9, 2020
Perception of barriers to research among internal medicine physician hospitalists by career stageSagar B Dugani, Holly L Geyer, Michael J Maniaci, et al.Critical Care Explorations|May 20, 2020
Increased Inpatient Length of Stay After Early Unplanned Transfer to Higher Levels of CareDaniel Sykora, Stephen J Traub, Matthew R Buras, et al.The Nurse Practitioner|August 23, 2020
Perspectives on and barriers to research among advanced practice provider and physician hospitalistsSagar B Dugani, Holly L Geyer, Michael J Maniaci, et al.Hospital Practice (1995)|October 5, 2020
Psychological wellness of internal medicine hospitalists during the COVID-19 pandemicSagar B Dugani, Holly L Geyer, Michael J Maniaci, et al.JAAPA : Official Journal of the American Academy of Physician Assistants|April 14, 2022
Psychologic wellness of PA, NP, and physician hospitalists during the COVID-19 pandemicSagar B Dugani, Karen M Fischer, Holly L Geyer, et al.Chest|August 5, 2011
Acute lung toxicity related to pomalidomideHolly L Geyer, Robert W Viggiano, Martha Q Lacy, et al.Hospital Practice (1995)|July 26, 2023
Global well-being, anxiety, social isolation, and emotional support among hospitalists during COVID-19 and Mpox outbreaksSagar B Dugani, Karen M Fischer, Darrell R Schroeder, et al.Journal of Hospital Medicine|May 10, 2022
Wellness of hospitalists and hospital medicine advanced practice providers during the COVID-19 pandemic, 2020-2021Sagar B Dugani, Karen M Fischer, Darrell R Schroeder, et al.Pageof 4